Next Article in Journal
The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy
Previous Article in Journal
Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
 
 
Article

Article Versions Notes

Cancers 2022, 14(16), 3843; https://doi.org/10.3390/cancers14163843
Action Date Notes Link
article xml file uploaded 9 August 2022 07:49 CEST Original file -
article xml uploaded. 9 August 2022 07:49 CEST Update https://www.mdpi.com/2072-6694/14/16/3843/xml
article pdf uploaded. 9 August 2022 07:49 CEST Version of Record https://www.mdpi.com/2072-6694/14/16/3843/pdf
article supplementary file uploaded. 9 August 2022 07:49 CEST - https://www.mdpi.com/2072-6694/14/16/3843#supplementary
article html file updated 9 August 2022 07:51 CEST Original file -
article supplementary file uploaded. 9 August 2022 08:07 CEST - https://www.mdpi.com/2072-6694/14/16/3843#supplementary
article html file updated 9 August 2022 08:08 CEST Update -
article html file updated 13 August 2022 06:17 CEST Update https://www.mdpi.com/2072-6694/14/16/3843/html
Back to TopTop